ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Mixed |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CACNA2D1 | Calcium channel, voltage-dependent, alpha 2/delta subunit 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | FDA approved drug targets Transporters
| | | | | Tissue enriched |
CACNG8 | Calcium channel, voltage-dependent, gamma subunit 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDND1 | Claudin domain containing 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
EPB41 | Erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Transporters
| | | | | Tissue enhanced |
MICU1 | Mitochondrial calcium uptake 1 | Disease related genes Potential drug targets Predicted secreted proteins Transporters
| | | | | Expressed in all |
RBP2 | Retinol binding protein 2, cellular | Transporters
| | | | | Group enriched |
SLC3A1 | Solute carrier family 3 (amino acid transporter heavy chain), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC3A2 | Solute carrier family 3 (amino acid transporter heavy chain), member 2 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A3R1 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 | Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
SLC9A3R2 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 | Transporters
| | | | | Mixed |
SMDT1 | Single-pass membrane protein with aspartate-rich tail 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
STOM | Stomatin | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TMEM30A | Transmembrane protein 30A | Predicted membrane proteins Transporters
| | | | | Expressed in all |
TSPAN7 | Tetraspanin 7 | CD markers Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |